GC
TMDX icon

Guggenheim Capital’s Transmedics TMDX Stock Holding History

Guggenheim Capital’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$212K Sell
2,137
-10,405
-83% -$1.36M ﹤0.01% 1507
2025
Q4 		$1.53M Buy
12,542
+10,146
+423% +$1.27M 0.01% 761
2025
Q3 		$269K Buy
2,396
+112
+5% +$13.1K ﹤0.01% 1421
2025
Q2 		$306K Buy
+2,284
New +$251K ﹤0.01% 1392
2024
Q4 		– Sell
-2,048
Closed -$322K – 1914
2024
Q3 		$322K Buy
+2,048
New +$316K ﹤0.01% 1583

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Guggenheim Capital's TMDX Position: Q1 2026 in Review

Guggenheim Capital reduced its Transmedics (TMDX) stake by 83% in Q1 2026, selling an estimated $1.36M and leaving 2,137 shares worth $212K. The position accounts for ﹤0.01% of the portfolio, ranked #1507.

Guggenheim Capital first reported a position in TMDX in Q3 2024 and has held it in 5 quarters since. The position peaked at $1.53M in Q4 2025. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Guggenheim Capital held 2,137 shares of Transmedics worth $212K as of Q1 2026.
  • Guggenheim Capital sold 10,405 Transmedics shares in Q1 2026, an estimated $1.36M.
  • Transmedics made up ﹤0.01% of Guggenheim Capital's portfolio in Q1 2026, its #1507 holding.
  • Guggenheim Capital first reported a position in Transmedics in Q3 2024 and has held it in 5 quarters since.
  • Guggenheim Capital's Transmedics position peaked at $1.53M in Q4 2025.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Guggenheim Capital's 13F filing for Q1 2026, filed 15 May 2026.